Ceftiofur Tazobactam 1125 mg injection in Veterinary PCD Franchise

Ceftiofur Tazobactam 1125 mg injection in Veterinary PCD Franchise

180 INR/Piece

Product Details:

  • Medicine Type Veterinary Injectables
  • Physical Form Powder
  • Ingredients Chemicals
  • Treatments & Functions The treatment of infections of the respiratory and alimentary tract.
  • Quantity/Volume 0.001125 Kilogram(Kg)
  • Storage Instructions At Room Temperature
  • Click to View more
X

Ceftiofur Tazobactam 1125 mg injection in Veterinary PCD Franchise Price And Quantity

  • 3000 Piece
  • 180 INR/Piece

Ceftiofur Tazobactam 1125 mg injection in Veterinary PCD Franchise Product Specifications

  • The treatment of infections of the respiratory and alimentary tract.
  • 0.001125 Kilogram(Kg)
  • Chemicals
  • Veterinary Injectables
  • Powder
  • At Room Temperature

Ceftiofur Tazobactam 1125 mg injection in Veterinary PCD Franchise Trade Information

  • Cash in Advance (CID), Cash Advance (CA)
  • 10000 Piece Per Month
  • 40 Days
  • Sample costs shipping and taxes has to be paid by the buyer
  • Customize
  • Middle East, Africa, Asia
  • Dadra and Nagar Haveli, Chandigarh, Andaman and Nicobar Islands, Uttarakhand, Daman and Diu, Lakshadweep, Delhi, Gujarat, South India, Central India, East India, West India, Andhra Pradesh, Assam, Arunachal Pradesh, Bihar, Goa, Haryana, Jammu and Kashmir, Jharkhand, Kerala, Madhya Pradesh, Maharashtra, Mizoram, Meghalaya, Manipur, Pondicherry, Rajasthan, Sikkim, Tamil Nadu, Telangana, Tripura, West Bengal, Nagaland, Uttar Pradesh, Karnataka, North India, Punjab, Odisha, Chhattisgarh, Himachal Pradesh, All India
  • GMP

Product Description

Ceftiofur sodium has demonstrated excellentin vitroandin vivoactivity againstMannheimia haemolyticaandPasteurella multocida, two of the major pathogenic organisms associated with bovine respiratory disease (pneumonia, shipping fever). This drug has also demonstrated excellentin vitroandin vivoactivity againstHistophilus somni (Haemophilus somnus)andin vitroactivity againstCorynebacterium pyogenes, two other bacterial pathogens associated with bovine respiratory disease (BRD). Ceftiofur has demonstratedin vivoandin vitroactivity againstFusobacterium necrophorumandBacteroides melaninogenicus, two of the major pathogenic anaerobic bacteria associated with acute bovine interdigital necrobacillosis (foot rot, pododermatitis). Ceftiofur has excellentin vitroactivity against Gram-negative pathogens such asActinobacillus pleuropneumoniae, Salmonella choleraesuis, Pasteurella multocidaand the Gram-positive pathogenStreptococcus suis, all of which singly or in combination can be associated with swine bacterial respiratory disease (swine bacterial pneumonia). Ceftiofur has also demonstrated excellentin vitroandin vivoactivity against respiratory pathogens of horses. The drug was very activein vitroagainstStreptococcus zooepidemicus, S. equi, Streptococcus spp.andPasteurella spp.isolated from patients with infections. Ceftiofur has demonstratedin vitroandin vivoactivity againstMannheimia haemolytica, the major pathogenic bacterium associated with ovine respiratory disease (pneumonia). Ceftiofur has also demonstratedin vivoandin vitroactivity against bacterial pathogens from dogs with urinary tract infections. Ceftiofur was more potent(in vitro)than other beta-lactam antibiotics against strains ofEscherichia coliandProteus mirabilisCeftiofur sodium has demonstrated excellentin vitroandin vivoactivity againstMannheimia haemolyticaandPasteurella multocida, two of the major pathogenic organisms associated with bovine respiratory disease (pneumonia, shipping fever). This drug has also demonstrated excellentin vitroandin vivoactivity againstHistophilus somni (Haemophilus somnus)andin vitroactivity againstCorynebacterium pyogenes, two other bacterial pathogens associated with bovine respiratory disease (BRD). Ceftiofur has demonstratedin vivoandin vitroactivity againstFusobacterium necrophorumandBacteroides melaninogenicus, two of the major pathogenic anaerobic bacteria associated with acute bovine interdigital necrobacillosis (foot rot, pododermatitis). Ceftiofur has excellentin vitroactivity against Gram-negative pathogens such asActinobacillus pleuropneumoniae, Salmonella choleraesuis, Pasteurella multocidaand the Gram-positive pathogenStreptococcus suis, all of which singly or in combination can be associated with swine bacterial respiratory disease (swine bacterial pneumonia). Ceftiofur has also demonstrated excellentin vitroandin vivoactivity against respiratory pathogens of horses. The drug was very activein vitroagainstStreptococcus zooepidemicus, S. equi, Streptococcus spp.andPasteurella spp.isolated from patients with infections. Ceftiofur has demonstratedin vitroandin vivoactivity againstMannheimia haemolytica, the major pathogenic bacterium associated with ovine respiratory disease (pneumonia). Ceftiofur has also demonstratedin vivoandin vitroactivity against bacterial pathogens from dogs with urinary tract infections. Ceftiofur was more potent(in vitro)than other beta-lactam antibiotics against strains ofEscherichia coliandProteus mirabilisCeftiofur sodium has demonstrated excellentin vitroandin vivoactivity againstMannheimia haemolyticaandPasteurella multocida, two of the major pathogenic organisms associated with bovine respiratory disease (pneumonia, shipping fever). This drug has also demonstrated excellentin vitroandin vivoactivity againstHistophilus somni (Haemophilus somnus)andin vitroactivity againstCorynebacterium pyogenes, two other bacterial pathogens associated with bovine respiratory disease (BRD). Ceftiofur has demonstratedin vivoandin vitroactivity againstFusobacterium necrophorumandBacteroides melaninogenicus, two of the major pathogenic anaerobic bacteria associated with acute bovine interdigital necrobacillosis (foot rot, pododermatitis). Ceftiofur has excellentin vitroactivity against Gram-negative pathogens such asActinobacillus pleuropneumoniae, Salmonella choleraesuis, Pasteurella multocidaand the Gram-positive pathogenStreptococcus suis, all of which singly or in combination can be associated with swine bacterial respiratory disease (swine bacterial pneumonia). Ceftiofur has also demonstrated excellentin vitroandin vivoactivity against respiratory pathogens of horses. The drug was very activein vitroagainstStreptococcus zooepidemicus, S. equi, Streptococcus spp.andPasteurella spp.isolated from patients with infections. Ceftiofur has demonstratedin vitroandin vivoactivity againstMannheimia haemolytica, the major pathogenic bacterium associated with ovine respiratory disease (pneumonia). Ceftiofur has also demonstratedin vivoandin vitroactivity against bacterial pathogens from dogs with urinary tract infections. Ceftiofur was more potent(in vitro)than other beta-lactam antibiotics against strains ofEscherichia coliandProteus mirabilis

FAQs of Ceftiofur Tazobactam 1125 mg injection in Veterinary PCD Franchise:


Q: What type of medicine is Ceftiofur Tazobactam 1125 mg injection?

A: Ceftiofur Tazobactam 1125 mg injection is a Veterinary Injectable medicine.

Q: What is the physical form of Ceftiofur Tazobactam 1125 mg injection?

A: The product is available in powder and liquid forms.

Q: What are the active ingredients in Ceftiofur Tazobactam 1125 mg injection?

A: The injection contains chemical-based ingredients.

Q: What is the recommended storage condition for this product?

A: Ceftiofur Tazobactam 1125 mg injection should be stored at room temperature.

Q: What infections does this product help treat?

A: The injection is used for the treatment of infections of the respiratory and alimentary tract.

Q: What is the quantity or volume of Ceftiofur Tazobactam 1125 mg injection?

A: The quantity/volume of the product is 0.001125 Kilogram (Kg).

Q: Is Ceftiofur Tazobactam 1125 mg injection an antibiotic?

A: Yes, this injection is classified as an antibiotic.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Veterinary PCD Injections' category



Back to top